Commerzbank Aktiengesellschaft Gilead Sciences, Inc. Transaction History

Commerzbank Aktiengesellschaft

$3.03 Billion
Q2 2024

A detailed history of Commerzbank Aktiengesellschaft transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 20,336 shares of GILD stock, worth $1.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

20,336

Previous 7,656 165.62%

Holding current value

$1.72 Million

Previous $561,000 148.66%

% of portfolio

0.05%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$63.15 - $72.88 $800,742 - $924,118	12,680 Added 165.62%	20,336 $1.4 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $214,740 - $261,870	3,000 Added 64.43%	7,656 $561,000
Q4 2023 Sep 30, 2024	SELL	$73.27 - $83.09 $1.15 Million - $1.3 Million	-15,680 Reduced 77.1%	4,656 $378,000
Q4 2023 Feb 01, 2024	BUY	$73.27 - $83.09 $341,145 - $386,867	4,656 New	4,656 $378,000
Q3 2022 Oct 02, 2024	SELL	$59.54 - $68.01 $718,707 - $820,948	-12,071 Reduced 59.36%	8,265 $510,000
Q3 2022 Sep 30, 2024	SELL	$59.54 - $68.01 $718,707 - $820,948	-12,071 Reduced 59.36%	8,265 $510,000
Q3 2022 Jun 08, 2023	BUY	$59.54 - $68.01 $492,098 - $562,102	8,265 New	8,265 $510,000
Q2 2020 Oct 03, 2024	BUY	$72.34 - $84.0 $3.13 Million - $3.63 Million	43,250 Added 212.68%	63,586 $4.89 Million
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $14.4 Million - $16.7 Million	-198,441 Closed	0 $0
Q1 2020 Oct 03, 2024	BUY	$62.63 - $80.22 $11.2 Million - $14.3 Million	178,105 Added 875.81%	198,441 $14.8 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $160,144 - $205,122	2,557 Added 1.31%	198,441 $14.8 Million
Q4 2019 Oct 03, 2024	BUY	$61.62 - $67.78 $10.8 Million - $11.9 Million	175,548 Added 863.24%	195,884 $12.7 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $5.55 Million - $6.11 Million	-90,077 Reduced 31.5%	195,884 $12.7 Million
Q3 2019 Oct 03, 2024	BUY	$62.51 - $69.0 $16.6 Million - $18.3 Million	265,545 Added 1305.79%	285,881 $18.1 Million
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $921,959 - $1.02 Million	-14,749 Reduced 4.9%	285,961 $18.1 Million
Q2 2019 Oct 03, 2024	BUY	$61.87 - $69.38 $17.3 Million - $19.4 Million	280,294 Added 1378.31%	300,630 $20.3 Million
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $4.3 Million - $4.82 Million	-69,534 Reduced 18.78%	300,710 $20.3 Million
Q1 2019 Oct 03, 2024	BUY	$62.53 - $70.05 $21.9 Million - $24.5 Million	349,678 Added 1719.5%	370,014 $24.1 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $4.32 Million - $4.83 Million	-69,020 Reduced 15.71%	370,244 $24.1 Million
Q4 2018 Oct 03, 2024	BUY	$60.54 - $79.0 $25.3 Million - $33 Million	418,353 Added 2057.2%	438,689 $27.4 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $6.31 Million - $8.24 Million	-104,268 Reduced 19.18%	439,264 $27.5 Million
Q3 2018 Oct 04, 2024	BUY	$71.28 - $78.92 $37.3 Million - $41.3 Million	523,696 Added 2575.22%	544,032 $42 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $8.44 Million - $9.34 Million	118,352 Added 27.84%	543,532 $42 Million
Q2 2018 Oct 04, 2024	BUY	$64.88 - $75.68 $26.3 Million - $30.7 Million	405,344 Added 1993.23%	425,680 $30.2 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $2.92 Million - $3.4 Million	44,970 Added 11.83%	425,180 $30.1 Million
Q1 2018 Oct 04, 2024	SELL	$72.84 - $88.8 $2.46 Million - $3 Million	-33,736 Reduced 8.12%	381,865 $28.8 Million
Q1 2018 May 01, 2018	SELL	$72.84 - $88.8 $2.35 Million - $2.86 Million	-32,236 Reduced 7.82%	380,210 $28.7 Million
Q4 2017 Oct 04, 2024	BUY	$71.15 - $83.52 $28.1 Million - $33 Million	395,265 Added 1943.67%	415,601 $29.8 Million
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $2.51 Million - $2.95 Million	-35,307 Reduced 7.89%	412,446 $29.5 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $6.28 Million - $7.44 Million	87,022 Added 24.12%	447,753 $36.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	360,731	360,731 $25.5 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account

Commerzbank Aktiengesellschaft Gilead Sciences, Inc. Transaction History